Search

Your search keyword '"Triolo, G"' showing total 939 results
Start Over Author "Triolo, G"
939 results on '"Triolo, G"'

252. Circulating complement fixing immune complexes in chronic hepatitis. Use of anti-C3 enzyme immunoassay to define antibody class and nature of antigen

Author

Sagnelli, E., Felaco, F. M., Triolo, G., Vernace, S. J., Pietro Filippini, Piccinino, F., Behrens, U., Paronetto, F., Sagnelli, E, Felaco, Fm, Triolo, G, Vernace, Sj, Filippini, Pietro, Piccinino, F, Behrens, U, and Paronetto, F.

Subjects
Immunoenzyme Techniques, Epitopes, Hepatitis B Surface Antigens, Liver, Cell Membrane, Humans, Immunoglobulins, Membrane Proteins, Proteins, Antigen-Antibody Complex, Complement C3, Complement Activation, Hepatitis, Chronic
Abstract

An anti-C3 enzyme immunoassay (anti-C3 EIA) was used to identify the antigen and antibody of immune complexes (IC). HBsAg, liver cell membrane antigens (LSP and LP-2), IgA, IgG and IgM were determined in IC of 258 patients with chronic active hepatitis (CAH) and 31 patients with chronic persistent hepatitis (CPH). IC that contained an antibody of either IgG, IgM or IgA class were detected in all types of CAH and CPH investigated. IC were seen more frequently in patients with cirrhosis than in CAH patients without cirrhosis and patients with CPH. LSP and LP-2 in IC were detected in 50% of patients with CAH and, infrequently, in CPH patients. In a group of 56 patients with CAH, followed for two to nine years, those patients treated with steroids showed a tendency to clear IC, whereas no variation was seen in untreated patients. While the presence of IC seems to indicate a decreased clearance of IC, a damaging activity of IC on the liver or the immune system remains to be demonstrated.

255. [Dialysis in high risk patients. Problems and results]

Author

Segoloni G, Triolo G, Stratta P, Alloatti S, Giacchino F, Giachino G, Pf, Martini, Giovanni Camussi, Paola M, Pacitti A, Coppo R, and Vercellone A

Subjects
Adult, Adolescent, Cardiovascular Diseases, Renal Dialysis, Neoplasms, Urinary Tract Infections, Humans, Kidney Failure, Chronic, Middle Aged, Aged
Published
1976

258. [Regular hemodialysis treatment in the diabetic patient]

Author

Piccoli, G., Triolo, G., Thea, A., Bosticardo, Gm, Grivet, V., Giorcelli, G., Roccatello, Dario, Bossi, P., Belardi, P., and Vercellone, A.

Subjects
Adult, Male, Risk, Adolescent, Myocardial Infarction, Infant, Ultrafiltration, Middle Aged, Diabetes Complications, Blood, Diabetic Neuropathies, Renal Dialysis, Child, Preschool, Humans, Female, Child, Aged, Uremia
Published
1982

261. [Use of amikacin in renal pathology]

Author

Triolo, G, Mangiarotti, G, Pacitti, A, Jeantet, A, Paola, M, Messina, M, Cardelli, R, Randone, D F, Porcellini, G, Martini, P F, and Segoloni, G P

Subjects
Adult, Male, Polycystic Kidney Diseases, Pyelonephritis, Bacterial Infections, Aged, Amikacin, Female, Glomerulonephritis, Humans, Kanamycin, Kidney Calculi, Kidney Diseases, Middle Aged, Urinary Tract Infections
Published
1981

264. First month cyclosporine A sparing in renal transplantation

Author

Segoloni, Gp, Messina, M, Colla, L, Piccoli, Giorgina Barbara, Triolo, G, and Vercellone, A.

Subjects
Graft Rejection, Immunosuppression Therapy, Dose-Response Relationship, Drug, Graft Survival, Cyclosporins, Opportunistic Infections, Kidney Transplantation, Methylprednisolone, Drug Administration Schedule, Creatinine, Humans, Prednisone, Kidney Diseases, Retrospective Studies
Published
1988

267. Exercise-induced microalbuminuria in diabetes is associated with the urinary excretion of cationic proteins

Author

Tetta C, Cavallo-Perin P, Roggero S, Malavasi F, Estivi P, Triolo G, Giovanni Camussi, and Pagano G

Subjects
Adult, Blood Platelets, Male, Adolescent, Kidney Glomerulus, albumin excretion, type I diabetic patients, Capillary Permeability, Proteinuria, Diabetes Mellitus, Type 1, Cations, Albuminuria, Humans, Female, Exercise
Abstract

Urinary protein components, highly cationic in nature (pI 10.9), with apparent molecular weights of 65 kD, 45 kD, and 28 kD were detected in type I diabetic patients before (2/7), during (4/7) and after (1/7) exercise. Based on the apparent isoelectric point and molecular weights, the urinary cationic components in the urines of type I diabetic patients were superimposable to purified cationic proteins derived from human platelets. Furthermore, they also shared common antigenic components as evidenced by the ability of a goat anti-human platelet-derived cationic protein serum to immunoprecipitate the 45 kD protein fraction. The latter induced vascular permeability when injected intradermally in the rabbit's skin. The occurrence of urinary cationic proteins was associated with the significant increase in albumin excretion rate (AER) in diabetic patients. No urinary cationic components were ever detected in the urines of 6 healthy subjects before, during, or after exercise. The possible pathogenetic relevance of the urinary excretion of cationic proteins in diabetic AER is discussed.

Published
1988

268. [Effects of Dose of Erythropoiesis Stimulating Agents on Cardiovascular Outcomes, Quality of Life and Costs of Haemodialysis. The Clinical Evaluation of the DOSe of Erythropoietins (C.E. DOSE) Trial]

Author

Saglimbene V, D'Alonzo D, Ruospo M, Vecchio M, Natale P, Gargano L, Nicolucci A, Pellegrini F, Jc, Craig, Triolo G, Da, Procaccini, Santoro A, Giulio S, Rosa S, Murgo A, Mammarella R, Sambati M, D'Ambrosio N, Greco V, Giannoccaro G, Flammini A, Boccia E, Montalto G, Pagano S, Amarù S, Fici M, Lumaga G, Mancini E, Veronesi M, Patregnani L, Querques M, Schiavone P, Chimienti S, Palumbo R, Franco D, Volpe M, Gori E, Salomone M, Iacono A, Moscoloni M, Treglia A, Casu D, Am, Piras, Silva A, Mandreoli M, Lopez A, Quarello F, Catizone L, Russo G, Forcellini S, Maccarone M, Catucci G, Paolo B, Stingone A, D'Angelo B, Guastoni C, Pasquali S, Minoretti C, Bellasi A, Boscutti G, Martone M, David S, Schito F, Urban L, Iorio B, Caruso F, Mazzoni A, Musacchio R, Andreoli D, Cossu M, Cavoli G, Cornacchiari M, Granata A, Clementi A, Giordano R, Barzaghi W, Miriam Valentini, Hegbrant J, Tognoni G, and Gf, Strippoli

Subjects
Risk, Dose-Response Relationship, Drug, Disease Management, Anemia, Middle Aged, Hemoglobins, Observational Studies as Topic, Double-Blind Method, Meta-Analysis as Topic, Renal Dialysis, Research Design, Outcome Assessment, Health Care, Hematinics, Quality of Life, Humans, Kidney Failure, Chronic, Diabetic Nephropathies, Female
Abstract

Anaemia is a risk factor for death, adverse cardiovascular outcomes and poor quality of life in patients with chronic kidney disease (CKD). Erythropoietin Stimulating Agents (ESA) are the most used treatment option. In observational studies, higher haemoglobin (Hb) levels (around 11-13 g/dL) are associated with improved survival and quality of life compared to Hb levels around 9-10 g/dL. Randomized studies found that targeting higher Hb levels with ESA causes an increased risk of death, mainly due to adverse cardiovascular outcomes. It is possible that this is mediated by ESA dose rather than haemoglobin concentration, although this hypothesis has never been formally tested.We present the protocol of the Clinical Evaluation of the Dose of Erythropoietins (C.E. DOSE) trial, which will assess the benefits and harms of a high versus a low ESA dose therapeutic strategy for the management of anaemia of end stage kidney disease (ESKD). This is a randomized, prospective open label blinded end-point (PROBE) design trial due to enroll 900 haemodialysis patients. Patients will be randomized 1:1 to 4000 UI/week i. v. versus 18000 UI/week i. v. of epoetin alfa, beta or any other epoetin in equivalent doses. The primary outcome of the trial is a composite of cardiovascular events. In addition, quality of life and costs of these two strategies will be assessed. The study has been approved and funded by the Italian Agency of Drugs (Agenzia Italiana del Farmaco (AIFA)) within the 2006 funding plan for independent research on drugs (registered at www.clinicaltrials.gov (NCT00827021)).

271. Epidemiology and risk factors in osteoarthritis: Literature review data from 'OASIS' study | Epidemiologia e fattori di rischio dell'osteoartrosi: Review della letteratura e dati dal progetto OASIS

Author

Filippis, L., Gulli, S., Caliri, A., Claudio Romano, Munaò, F., Trimarchi, G., La Torre, D., Fichera, C., Pappalardo, A., Triolo, G., Gallo, M., Valentini, G., Bagnato, G., Acampora, R., Accardi, A., Arrigo, C., Barbagallo, M., Barbuto, G., Bartolone, S., Bocchino, L., Califano, E., Candiote, G., Carpinelli, A., Chirico, G., Ciccia, F., Cuzzucoli, M., Corsaro, S. M., D Avola, G., Gaetano, P., Grasso, E., Silva, S., Di Girolamo, C., Di Paola, A., Di Stefano, R., Farina, G., Ferrante, A., Foti, R., Galfo, G., Italiano, G., Iuliano, P., La Trecchia, A., Lo Gullo, R., Lordi, G., Mantova, D., Manzo, C., Marino, F., Miceli, G., Molica, C. A., Montaruli, M., Morgante, L., Muccari, G., Muratore, A., Nutile, G., Peruz, G. G., Pinelli, P., Pistone, G., Pucino, A., Quattrocchi, E., Raffa, G., Russo, R., Sambataro, A., Sangari, D., Scarpato, S., Scibilia, G., Scognamiglio, A., Spanò, A., Spataro, M., Stisi, S., Tirri, R., Toriello, G., Torre, R., Tropea, S., and Varcasia, G.

272. Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial | Effetti della dose degli agenti stimolanti l'eritropoiesi su esiti cardio-cerebrovascolari, qualità di vita e costi in emodialisi

Author

Saglimbene, V., D Alonzo, D., Ruospo, M., Vecchio, M., Natale, P., Gargano, L., Nicolucci, A., Pellegrini, F., Craig, J. C., Triolo, G., Procaccini, D. A., Santoro, A., Di Giulio, S., La Rosa, S., Murgo, A., Di Toro Mammarella, R., Sambati, M., D Ambrosio, N., Greco, V., Giannoccaro, G., Flammini, A., Boccia, E., Giuseppe MONTALTO, Pagano, S., Amarù, S., Fici, M., Lumaga, G. B., Mancini, E., Veronesi, M., Patregnani, L., Querques, M., Schiavone, P., Chimienti, S., Palumbo, R., Di Franco, D., Della Volpe, M., Gori, E., Salomone, M., Iacono, A., Moscoloni, M., Treglia, A., Casu, D., Piras, A. M., Di Silva, A., Mandreoli, M., Lopez, A., Quarello, F., Catizone, L., Russo, G., Forcellini, S., Maccarone, M., Catucci, G., Di Paolo, B., Stingone, A., D Angelo, B., Guastoni, C., Pasquali, S., Minoretti, C., Bellasi, A., Boscutti, G., Martone, M., David, S., Schito, F., Urban, L., Di Iorio, B., Caruso, F., Mazzoni, A., Musacchio, R., Andreoli, D., Cossu, M., Li Cavoli, G., Cornacchiari, M., Granata, A., Clementi, A., Giordano, R., Barzaghi, W., Valentini, M., Hegbrant, J., Tognoni, G., and Strippoli, G. F.

274. Protein Z G79A and A-13G gene polymorphisms in Italian patients with Behçet's disease

Author

Ghinoi, A., Boiardi, L., Atzeni, F., Casali, B., Farnetti, E., Nicoli, D., Pipitone, N., Olivieri, I., Cantini, F., Salvi, F., La Corte, R., Triolo, G., Filippini, D., Paolazzi, G., and Carlo Salvarani

Subjects
Adult, Behcet Syndrome, Blood Proteins, Case-Control Studies, Factor V, Female, Humans, Introns, Italy, Male, Prothrombin, Venous Thrombosis, Young Adult, Polymorphism, Single Nucleotide, Single Nucleotide, Polymorphism
Abstract

To investigate potential associations between A-13G and G79A polymorphisms of the protein Z gene and venous thrombosis and other clinical manifestations in Italian patients with Behçet's disease (BD).176 Italian patients who satisfied the International Study Group criteria for BD and 134 healthy age- and sex- matched blood donors were genotyped for A-13G and G79A polymorphisms of the protein Z gene by molecular methods. 113 and 112 of the 176 BD patients were also genotyped for factor V Leiden and prothrombin gene G20210A polymorphisms. Serological HLA class B51 typing was performed by a standard microlymphocytotoxicity technique. The patients were subgrouped according to the presence or absence of clinical manifestations.The distribution of allele and genotype frequencies of A-13G and G79A polymorphisms did not differ significantly between BD patients and healthy controls.The frequencies of carriage rates of protein Z G79A and A-13G polymorphisms in BD patients with and without DVT were similar. Similarly, no associations between thrombotic events and the protein Z gene polymorphisms studied were observed in BD patients carrying factor V Leiden or prothrombin gene G20210A mutations. No significant associations were observed between protein Z polymorphisms and the occurrence of specific clinical findings.No association between DVT and A-13G or G79A polymorphisms of the protein Z gene was found in Italian BD patients. Furthermore, these protein Z polymorphisms in BD do not seem to increase the risk of DVT due to factor V Leiden or prothrombin gene G20210A mutations.

275. [Significance of the study of complement in glomerulonephritis. Research on some serum complement fractions and their detection in renal biopsies with the use of microscopy and immunofluorescence]

Author

Pf, Martini, Giovanni Camussi, Segoloni G, Rotunno M, Triolo G, Mangiarotti G, Messina M, and Caramello E

Subjects
Glomerulonephritis, Microscopy, Fluorescence, Kidney Glomerulus, Animals, Fluorescent Antibody Technique, Humans, Lupus Erythematosus, Systemic, Complement C4, Complement C3, Complement System Proteins, Kidney, Complement C8

277. The Italian registry of aggressive rheumatoid arthritis - The GIARA project

Author

Marchesoni, A., Govoni, M., Valentini, G., Valesini, G., Salaffi, F., Macchioni, P., Della Casa Alberighi, O., Ferraccioli, G., Accardi, A., Adami, S., Arioli, G., Bagnato, G., Bambara, L. M., Bianchi, G., Bombardieri, S., Broggini, M., Cacace, E., Califano, E., Campaniello, N., Canesi, B., Carignola, R., Carniello, G., Carrabba, M., Cassisi, G., Ciompi, M. L., Clerico, P., Coaccioli, S., Concesi, C., Consonni, G., Corsaro, S., Davoli, C., Cata, A., Del Frate, M., Della Corte, G., Di Giuseppe, P., Di Matteo, L., Diamanti, M., Evangelista, L., Fietta, P., Fusconi, M., Gabrielli, A., Gardinali, M., Ghirardini, M., Roberto Giacomelli, Gorla, R., Gusi, R., La Palombara, F., Lapadula, G., Leone, M., Limonta, M., Lo Gulfo, R., Lovino, C., Manganelli, P., Mantova, D., Marello, P. G., Martini, F., Mascia, M. T., Mastaglio, C., Mathieu, A., Mattara, L., Matucci, M., Mazzanto, G., Meschini, C., Migliore, A., Minisola, G., Modena, V., Morassi, P., Muratore, M., Nuvoli, G., Olivieri, I., Oriente, P., Ostuni, P., Paolazzi, G., Pellerito, R., Peronato, G., Pistone, G., Provenzano, G., Pucino, A., Pusceddu, M., Raffa, G., Rigotti, R., Rondana, M., Russo, R., Sabadini, L., Sabbattini, M. G., Scapato, P., Scarpato, S., Sebastiani, G. D., Steinhauser, K., Tocci, G., Torre, R., Triolo, G., Trotta, A., Vinicola, V., Vitali, C., and Volante, D.

279. Update of the Italian Society of Nephrology Project No. 1 of the 2004-2006 SIN programme,Update sul progetto SIN n. 1 del programma SIN 2004-2006: qualità e accreditamento delle strutture di nefrologia, dialisi e trapianto

Author

Manno, C., Virgilio, M., Giangrande, A., Stalteri, A., Contu, B., Quintaliani, G., Spinelli, C., Avella, F., Cappelli, G., FRANCESCO CASINO, Cicchetti, T., Di Giulio, S., Di Luca, M., Meneghel, G., Milone, F., Moriconi, L., Panzetta, G. O., Procaccini, A. D., Triolo, G., and Zoccali, C.

281. Epidemiology and risk factors in osteoarthritis: Literature review data from 'OASIS' study,Epidemiologia e fattori di rischio dell'osteoartrosi: Review della letteratura e dati dal progetto OASIS

Author

Filippis, L., Gulli, S., Caliri, A., Romano, C., Munaò, F., Giuseppe TRIMARCHI, La Torre, D., Fichera, C., Pappalardo, A., Triolo, G., Gallo, M., Valentini, G., Bagnato, G., Acampora, R., Accardi, A., Arrigo, C., Barbagallo, M., Barbuto, G., Bartolone, S., Bocchino, L., Califano, E., Candiote, G., Carpinelli, A., Chirico, G., Ciccia, F., Cuzzucoli, M., Corsaro, S. M., D Avola, G., Gaetano, P., Grasso, E., Silva, S., Di Girolamo, C., Di Paola, A., Di Stefano, R., Farina, G., Ferrante, A., Foti, R., Galfo, G., Italiano, G., Iuliano, P., La Trecchia, A., Lo Gullo, R., Lordi, G., Mantova, D., Manzo, C., Marino, F., Miceli, G., Molica, C. A., Montaruli, M., Morgante, L., Muccari, G., Muratore, A., Nutile, G., Peruz, G. G., Pinelli, P., Pistone, G., Pucino, A., Quattrocchi, E., Raffa, G., Russo, R., Sambataro, A., Sangari, D., Scarpato, S., Scibilia, G., Scognamiglio, A., Spanò, A., Spataro, M., Stisi, S., Tirri, R., Toriello, G., Torre, R., Tropea, S., and Varcasia, G.

282. Myotonic dystrophy and craniofacial morphology: clinical and instrumental study

Author

Portelli, M., Giovanni Matarese, Militi, A., Nucera, R., Triolo, G., and Cordasco, G.

Subjects
Adult, Male, Skull Base, Chin, Adolescent, Cephalometry, Skull, Myotonic dystrophy, Open Bite, Craniofacial growth, Orofacial musculature, Mandible, Nose, Models, Dental, Young Adult, Photography, Dental, Maxilla, Humans, Female, Age of Onset, Child, Maxillofacial Development
Abstract

The aim of this study is to assess if, and to what extent, myotonic dystrophy can affect the craniofacial growth pattern.The research was conducted on a sample of 27 patients with Steinert's myotonic dystrophy (study group). Each subject underwent a clinical examination with impression-taking and intra- and extraoral photographs. A latero-lateral projection teleradiography in the mirror position was also taken and a cephalometric examination was performed. The assessed values were compared with those obtained from a group of healthy subjects (control group).Statistical analysis of the data obtained from the myotonic patients who developed the disease during the growth phase revealed alterations in the transversal plane and, to an even greater extent, the vertical one, with a high frequency of anterior open bite. Discussion and conclusions Regarding the pathogenesis of these types of skeletal dysplasias, the authors hypothesise a posterior rotation growth pattern, resulting from gravitational force prevailing over the deficit of the elevator muscles.

283. [Current trends and criteria in choice of frequency of dialytic treatments]

Author

Segoloni G, Triolo G, Mangiarotti G, Giacchino F, Coppo R, Giovanni Camussi, Canavese C, Pacitti A, Alloatti S, Quarello F, Ragni R, and Stratta P

Subjects
Hospitalization, Periodicity, Time Factors, Renal Dialysis, Hemodialysis, Home, Humans, Kidney Failure, Chronic, Prognosis, Peritoneal Dialysis, Kidneys, Artificial

284. The effect of hemodiafiltration with on-line endogenous reinfusion (on-line HFR) on anemia: Design of a European, open, randomised, multicentre trial

Author

Cerulli, N., La Greca, G., Laville, M., Palla, R., Ramello, A., Ghezzi, P. M., Fouque, D., Pizzarelli, F., Schena, Fp, Tetta, C., Buades, J., Giovanni Camussi, David, S., Hoerl, W., Triolo, G., Maggiore, U., Chiarulli, G., Losurdo, N., Petrarulo, F., Sacchetti, A., Pallotta, G., Dagostino, F., Del Mastro, G., Sasdelli, M., Mura, C., Bongiorno, P., Grill, A., Varvara, M., Carabellese, S., Laraia, E., Rizzi, R., Mancini, A., Losappio, R., Maiorca, R., Movilli, E., Scolari, F., Fiorini, F., Imperatore, P., Ranieri, F., Bozzi, M., Cuzzola, R., Min, A., Specchio, A., Bonomini, M., Cuonzo, Mt, Di Bari, M., Dogliani, M., Fidelio, T., Meinero, S., Canepari, G., Surian, M., Bonforte, G., Rivera, R., Sangalli, L., Broccoli, R., Maggiore, Q., Cavatorta, F., Zollo, A., Mastrangelo, F., Blasi, V., Alfonso, L., Usberti, M., Rondina, M., Combarnous, F., Basile, C., Giordano, R., Betti, G., Lopez, T., Casino, F., Ponticelli, C., Valenti, G., Ambroso, G., Como, G., Barbiano Di Belgioioso, G., Bertoli, S., Buzzi, L., Albertazzi, A., Lucchi, L., Virgilio, M., Giancaspro, V., Pastore, G., Conversano, A., Testa, A., Malcangi, U., Reina, E., Rusconi, L., Meterangelis, A., Amato, M., Campolo, G., Giachino, G., Chiappero, F., Carozzi, S., Schelotto, C., and Sanna, A.

286. Guidelines audit may overcome disparities in health care: Experience of an Italian region

Author

Salomone, M., Canavese, C., Bergamo, D., Hollo, Z., Damiani, D., Maffei, S., Fenoglio, R., Bermond, F., Vincenzo CANTALUPPI, Quaglia, M., and Triolo, G.

Subjects
Chronic Kidney Disease-Mineral and Bone Disorder, Male, Medical Audit, Anemia, Middle Aged, Treatment Outcome, Italy, Renal Dialysis, Practice Guidelines as Topic, Humans, Female, Guideline Adherence, Aged, Uremia
Abstract

A clinical audit is used to verify the application of evidence-based clinical guidelines. Our regional section of the Italian Society of Nephrology was the first to establish a region-based program of clinical audits of compliance with guidelines for treating osteodystrophy and anemia of patients on chronic dialysis. This study summarizes the main results of the 2 audits of the Piemonte region.Structured questionnaires were sent twice to all of the 22 dialysis centers of Piemonte and to the Center of Valle D'Aosta for an Audit on Osteodystrophy (in 2000 and 2004) and for the Audit on Anemia (2003). The questionnaires were meant to evaluate the clinical schedule of treatment relative to calcium-phosphate balance and anemia in dialysis patients.All centers responded, showing low levels of agreement with the targets of Italian guidelines. In sum, in 2000 only 27% of centers had more than 70% of patients with serum phosphate5.5 mg/dL, but that rate had increased to 33% in 2004. Only 35% (in 2000) and 40% (in 2004) of the centers had more than 90% of patients with Kt/V1.2. The Audit on Anemia showed a median of 42% of patients with hemoglobin between 11 and 12 g/dL, and only 2 centers had more than 70% of patients above this target.The first result of our pioneering experience was that we found that compliance with minimal levels of care was still inadequate, with regard to hyperphosphatemia, dialysis adequacy and anemia. Nevertheless, the 2nd Audit on Osteodystrophy showed a relative improvement in the results. But, most importantly, this open regional report has encouraged comparisons, and motivated centers to adopt a strategy of understanding, addressing and correcting inadequate levels of care, and furthermore increased satisfaction with the care being offered.

287. Factors influencing pain, physical function and social functioning in patients with osteoarthritis in Southern Italy

Author

Filippis, L. G., Gulli, S., Caliri, A., D Avola, G., Lo Gullo, R., Morgante, S., Romano, C., Munaò, F., Trimarchi, G., La Torre, D., Fichera, C., Pappalardo, A., Triolo, G., Gallo, M., Valentini, G., Bagnato, G., Acampora, R., Accardi, A., Arrigo, C., MARIO BARBAGALLO, Barbuto, G., Bartolone, S., Bocchino, L., Califano, E., Candioto, G., Carpinelli, A., Chirico, G., Ciccia, F., Cuzzucoli, M., Corsaro, S. M., Gaetano, P., Grasso, E., Silva, S., Di Girolamo, C., Di Paola, A., Di Stefano, R., Farina, G., Ferrante, A., Foti, R., Galfo, G., Gigliotti, P., Italiano, G., Iuliano, P., La Trecchia, A., Lordi, G., Mantova, D., Manzo, C., Marino, F., Miceli, G., Migliorato, G., Molica Colella, A., Montaruli, M., Morgante, L., Muccari, G., Muratore, A., Nutile, G., Peruz, G. G., Pinelli, P., Pistone, G., Pucino, A., Quattrocchi, E., Raffa, G., Russo, R., Sambataro, A., Sangari, D., Scarpato, S., Scibilia, G., Scognamiglio, A., Spanò, A., Spataro, M., Stisi, S., Tirri, R., Toriello, G., Torre, R., Tropea, S., and Varcasia, G.

288. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care

Author

Salaffi, F., Ciapetti, A., Gasparini, S., Marina CAROTTI, Bombardieri, S., Laganà, B., Varcasia, G., Pomponio, G., Mozzani, F., Scarpa, R., Maier, A., Romeo, N., Migliore, A., Scarpellini, M., Corsaro, S. M., Pusceddu, M., Rotondi, R. F., Foti, R., Marasini, B., Ferraccioli, G., Malavolta, N., Sabadini, L., Cimmino, M., Ricioppo, A., Triolo, G., Mascia, M. T., Minisola, G., Botsios, K., Pellerito, R., Noto, A., and Cazzato, M.

292. Acute Renal Failure in Fulminating Beriberi

Author

Stratta, P., primary, Canavese, C., additional, Triolo, G., additional, Segoloni, G., additional, Pacitti, A., additional, Salomone, M., additional, Mangiarotti, G., additional, and Vercellone, A., additional

Published
1986
Full Text
View/download PDF

298. Acute Renal Failure in Fulminating Beriberi

Author

Caterina Canavese, Mario Salomone, Triolo G, Piero Stratta, Antonio Vercellone, A. Pacitti, Giovanni Mangiarotti, and Segoloni Gp

Subjects
medicine.medical_specialty, business.industry, 030232 urology & nephrology, Biomedical Engineering, Medicine (miscellaneous), Bioengineering, General Medicine, 030204 cardiovascular system & hematology, Beriberi, medicine.disease, Biomaterials, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Cardiology, business
Published
1986

300. Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis.

Author

Ferrante, A, Ciccia, F, Guggino, G, Colomba, D, and Triolo, G

Subjects
INTERMITTENT claudication, DYSPNEA, THERAPEUTIC use of monoclonal antibodies, PULMONARY hypertension, TAKAYASU arteritis, DISEASE complications
Abstract

A letter to the editor is presented which discusses the case study of a 46-year-old female white patient with upper extremity claudication, dyspnoea, and weight loss and has been diagnosed with Takayasu arteritis (TA).

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results